Revision history of "MOLECULAR CHARACTERISATION OF CANINE BREAST CARCINOMA AT THE TISSUE AND PLASMATIC LEVEL" (Q3135597)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

22 March 2024

20 December 2023

12 June 2023

10 June 2023

1 March 2023

22 February 2023

17 August 2022

  • curprev 18:5618:56, 17 August 2022DG Regio talk contribs 66,077 bytes +44,792 Changed label, description and/or aliases in el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl, nl, fr, de, it, es, and other parts: Adding translations: el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl,

16 January 2022

17 December 2021

9 December 2021

2 December 2021

  • curprev 08:0808:08, 2 December 2021DG Regio talk contribs 14,400 bytes +2,293 Created claim: summary (P836): AVEC DES ÉTUDES ANTÉRIEURES SUR LES TUMEURS MAMMAIRES CANINES (PM98-0164, AGL03-6289, AGL2006-09016, CVI-P07-02559, AGL2011-025553), NOUS AVONS MONTRÉ QUE: LES TUMEURS DES RÉCEPTEURS D’ŒSTROGÈNE (RÉ) ET DE PROGESTÉRONE (RP) ONT DES TAUX DE RÉCURRENCE PLUS FAIBLES ET UNE EXPRESSION PLUS FAIBLE DE SON-2 ET RÉPONDENT AU TRAITEMENT ENDOCRINIEN AVEC UNE DIMINUTION DE LA PROLIFÉRATION CELLULAIRE IN VIVO ET IN VITRO; ET II) QUE LA POPULATION CELLULAIRE...
  • curprev 08:0808:08, 2 December 2021DG Regio talk contribs 12,107 bytes +151 Changed label, description and/or aliases in fr: translated_label

12 October 2021

  • curprev 12:3612:36, 12 October 2021DG Regio talk contribs 11,956 bytes +146 Changed label, description and/or aliases in en: translated_label
  • curprev 12:3612:36, 12 October 2021DG Regio talk contribs 11,810 bytes +2,080 Created claim: summary (P836): WITH PREVIOUS STUDIES ON CANINE BREAST TUMORS (PM98-0164, AGL03-6289, AGL2006-09016, CVI-P07-02559, AGL2011-025553) WE HAVE SHOWN THAT: ESTROGEN RECEPTOR (RE) AND PROGESTERONE (RP) RECEPTOR TUMORS HAVE LOWER RECURRENCE RATES AND LOWER HER-2 EXPRESSION AND RESPOND TO ENDOCRINE TREATMENT WITH A DECREASE IN CELL PROLIFERATION IN VIVO AND IN VITRO; AND II) THAT THE MOST HETEROGENEOUS CELL POPULATION IN TERMS OF MORPHOLOGY AND IMMUNOPHENOTYPE IS THAT...

10 October 2021

9 October 2021

7 October 2021